Take a look at this year’s top articles — one showcasing enhanced weight loss through Semaglutide use in post-menopausal ...

Kamilia Smith, MD, FACOG, NCMP, discusses how educating patients about the serious long-term health risks of untreated vasomotor symptoms (VMS) requires a comprehensive strategy that includes clear ...

This year’s top dermatology posts on Managed Healthcare Executive include stories about Gen Z sunscreen trends and increasing ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...